Moy B, Rumble RB, Come SE, Davidson NE, et al. Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update. J Clin Oncol 2021 Jul 29:JCO2101374. doi: 10.1200/JCO.21.01374.
PMID: 34324366